Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-05

Clinical Trial Update: High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial comparing high-dose or standard-dose radiation therapy with chemotherapy, with or without cetuximab, in newly diagnosed stage III non-small cell l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetuximab (cetuximab)
  • Standard chemotherapy regimens

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Lung Cancer, Radiation Toxicity | Phase 3 | Status: COMPLETED | Results posted: 2017-05-05